ABG Sundal Collier Holding ASA (ABG)
Oslo Børs · Norway · prices in NOK · close of 27 Oct 2026
Key indicators
| Last close | NOK 7.170 |
|---|---|
| 52-week range | 6.950 – 8.400 |
| Return, 1 month / 3 months | −1.8% / +1.4% |
| Return, 1 year / 3 years | +8.9% / +76.1% |
| Trend | Below its 200-day average |
| RSI (14) | 45 |
| Volatility (1 year) | 17.3% |
| Worst drawdown (1 year) | -10.6% |
| Average daily value traded | 3.64M NOK |
| Dividend yield | 7.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
ABG Sundal Collier is an investment bank based in Oslo, Norway, serving companies and institutional investors across the Nordic region and beyond. It advises on mergers and acquisitions, equity capital markets transactions and other corporate finance matters, and it provides equity research, sales and trading, and brokerage services. Its clients include corporations, financial institutions and investment managers who rely on the firm for advice on transactions and for access to Nordic securities markets.
ABG Sundal Collier Holding ASA trades under the code ABG on the Oslo Børs in Norway, with its price quoted in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
ABG Sundal Collier Holding ASA (ABG) trades on the Oslo Børs in Norway. It last closed at NOK 7.170 on 27 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 87 of 294 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 8.9% and over the last three months it rose 1.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Oslo Børs
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 50 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -2.1% | ||
| From 52-week high | -14.1% | ||
| Momentum | 52 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 1.4% | ||
| 6-month return | -0.8% | ||
| 12-month return, skipping the last month | 10.9% | ||
| Stability (higher is calmer) | 96 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 17.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -10.6% | ||
| Liquidity | 56 · Fair | Moderate trading activity. | |
| Average daily value traded | 3.64M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | 65 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 7.7% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | −1.8% |
| 3 months | +1.4% |
| 6 months | −0.8% |
| 1 year | +8.9% |
| 3 years | +76.1% |
| 5 years | +20.8% |
Signals
| 50-day / 200-day average | 7.294 / 7.324 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.126 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Apr 2026 | NOK 0.5500 |
| 25 Apr 2025 | NOK 0.5000 |
| 19 Apr 2024 | NOK 0.5000 |
| 27 Apr 2023 | NOK 0.5000 |
| 27 Apr 2022 | NOK 1.0000 |
| 21 Apr 2021 | NOK 0.8300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Oslo Børs; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.